Heart disease is the leading cause of death for Americans. Kaiser Permanente Washington Health Research Institute (KPWHRI) scientists are working to understand how to reduce our risk of heart attacks, stroke, and other cardiovascular diseases throughout life.
Addressing risk factors, improving diagnosis, and exploring how medications, genes, and everyday life affect our cardiovascular health at different ages and stages are central to this work — as is translating research findings into practical, personalized care.
“We’ve found that helping patients and health care teams work together on personalized care plans is the best path to lifelong heart health,” says Beverly Green, MD, MPH, whose recent work has focused on improving the diagnosis of high blood pressure.
Additional focus areas for KPWHRI scientists include exploring the impact of cardiovascular diseases on other health conditions — and vice versa. Recently, this has led researchers Sascha Dublin, MD, PhD, and Laura B. Harrington, PhD, MPH, to investigate the impact of COVID-19 on cardiovascular health.
Below are other research highlights from KPWHRI’s cardiovascular health scientists (please visit their bios to learn more):
Munsch G, Thibord F, Bezerra OC, Brody JA, van Hylckama Vlieg A, Gourhant L, Chen MH, Samaria F, Germain M, Caro I, Suchon P, Olaso R, Wiggins KL, Saut N, Besse C, Goumidi L, Bacq D, Harrington LB, Boland A, Emmerich J, Smadja DM, Lemarié CA, Danckwardt S, Debette S, Deleuze JF, Jacqmin-Gadda H, Rodger MA, Gagnon F, Rosendaal FR, Johnson AD, Smith NL, Couturaud F, Morange PE, Trégouët DA Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes 2025 Nov 6;146(19):2357-2369 doi:10.1182/blood.2024027879. doi: 10.1182/blood.2024027879. Epub 2025-08-14. PubMed
Rossouw JE, Aragaki AK, Manson JE, Szmuilowicz ED, Harrington LB, Johnson KC, Allison M, Haring B, Saquib N, Shadyab AH, Rexrode KM, Liu L, Mouton CP, LaCroix AZ Menopausal Hormone Therapy and Cardiovascular Diseases in Women With Vasomotor Symptoms: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials 2025 Nov;185(11):1330-1339 doi:10.1001/jamainternmed.2025.4510. doi: 10.1001/jamainternmed.2025.4510. Epub 2025-09-15. PubMed
Davis JW, Aragaki AK, Harrington LB, Rossouw JE, Wells G, Shadyab A, Schnatz PF, Shufelt CL, Warsinger-Martin L, Wild RA, Manson JE Baseline use of aspirin or statins with oral estrogen and progestogens to prevent incident arterial or venous thrombotic events: a secondary analysis of the Women's Health Initiative trial 2025 Oct 21 doi: 10.1097/GME.0000000000002647. Epub 2025-10-21. PubMed
Green BB, Hansell LD, Hsu CW, Jones T, Luce C, Ralston JD, Munson SA, Davis B, Wright T, Anderson ML Evaluation of an Email Blood Pressure Measurement Outreach Program 2025 Oct 15 doi: 10.1093/ajh/hpaf206. Epub 2025-10-15. PubMed
Frauenheim AC, Wiggins KL, Lemaitre RN, Smith NL, Harrington LB Physical activity before venous thromboembolism and risk of recurrence in a population-based inception cohort 2025 Sep 4 doi: 10.1007/s11239-025-03127-w. Epub 2025-09-04. PubMed
Meagan C. Brown, PhD, MPHAssistant Investigator |
Sascha Dublin, MD, PhDSenior Investigator |
Nicole M. Gatto, PhD, MPHPrincipal Collaborative Scientist |
Beverly B. Green, MD, MPHSenior Investigator |
Laura Harrington, PhD, MPHAssociate Investigator |
James Floyd, MD, MS
Assistant Professor, Department of Medicine
Adjunct Assistant Professor, Department of Epidemiology
University of Washington
Susan Heckbert, MD, PhD
University of Washington (UW) Department of Epidemiology; UW Cardiovascular Health Research Unit
Nicholas L. Smith, PhD, MPH
UW Professor, Epidemiology, Cardiovascular Health Research Unit
Director, Seattle Epidemiology and Information Resource Center, VA Puget Sound Health Care System